BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 7082083)

  • 21. Mediastinal nodal involvement and the prognosis of non-small cell lung cancer.
    Watanabe Y; Hayashi Y; Shimizu J; Oda M; Iwa T
    Chest; 1991 Aug; 100(2):422-8. PubMed ID: 1650679
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The prognostic significance of preoperative assessment of mediastinal lymph nodes in patients with lung cancer.
    Ratto GB; Mereu C; Motta G
    Chest; 1988 Apr; 93(4):807-13. PubMed ID: 3349839
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Value of perioperative brachytherapy in the management of non-oat cell carcinoma of the lung.
    Hilaris BS; Nori D; Beattie EJ; Martini N
    Int J Radiat Oncol Biol Phys; 1983 Aug; 9(8):1161-6. PubMed ID: 6874448
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bronchogenic carcinoma: a study of patients treated at Capital Hospital, Peking, China.
    Xu LT; Sun CF; Li ZJ; Wu LH
    Ann Thorac Surg; 1982 Jun; 33(6):605-8. PubMed ID: 6284076
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Value of systematic mediastinal lymph node dissection during pulmonary metastasectomy.
    Loehe F; Kobinger S; Hatz RA; Helmberger T; Loehrs U; Fuerst H
    Ann Thorac Surg; 2001 Jul; 72(1):225-9. PubMed ID: 11465184
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Resection for bronchogenic carcinoma involving the carina: long-term results and effect of nodal status on outcome.
    Mitchell JD; Mathisen DJ; Wright CD; Wain JC; Donahue DM; Allan JS; Moncure AC; Grillo HC
    J Thorac Cardiovasc Surg; 2001 Mar; 121(3):465-71. PubMed ID: 11241081
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Radiation therapy following resection of non-small cell bronchogenic carcinoma.
    Slater JD; Ellerbroek NA; Barkley HT; Mountain C; Oswald MJ; Roth JA; Peters LJ
    Int J Radiat Oncol Biol Phys; 1991 May; 20(5):945-51. PubMed ID: 1850721
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Proposal for reasonable mediastinal lymphadenectomy in bronchogenic carcinomas: role of subcarinal nodes in selective dissection.
    Okada M; Tsubota N; Yoshimura M; Miyamoto Y
    J Thorac Cardiovasc Surg; 1998 Dec; 116(6):949-53. PubMed ID: 9832685
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Results of surgical resection of stage IIIa (N2) non small cell lung cancer, according to the site of the mediastinal metastases.
    Maggi G; Casadio C; Cianci R; Molinatti M; Filosso PL; Nicolosi M; Oliaro A
    Int Surg; 1993; 78(3):213-7. PubMed ID: 8276543
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognosis of completely resected pN2 non-small cell lung carcinomas: What is the significant node that affects survival?
    Okada M; Tsubota N; Yoshimura M; Miyamoto Y; Matsuoka H
    J Thorac Cardiovasc Surg; 1999 Aug; 118(2):270-5. PubMed ID: 10425000
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Systemic radiation and split-course radiotherapy for non-small-cell bronchial carcinoma.
    Qasim M
    Clin Radiol; 1986 Jan; 37(1):51-3. PubMed ID: 3956094
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Results after surgery in stage-I bronchogenic carcinoma.
    Wertzel H; Siebert H; Lange W; Swoboda L; Graf E; Hasse J
    Thorac Cardiovasc Surg; 1998 Dec; 46(6):365-9. PubMed ID: 9928860
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preoperative x-ray therapy as an adjuvant in the treatment of bronchogenic carcinoma.
    Shields TW; Higgins GA; Lawton R; Heilbrunn A; Keehn RJ
    J Thorac Cardiovasc Surg; 1970 Jan; 59(1):49-61. PubMed ID: 5410189
    [No Abstract]   [Full Text] [Related]  

  • 34. A contribution on the prognostic significance of the tumor formula (pTNM) in squamous cell carcinoma of the bronchus.
    Huwer H; Volkmer I; Hülsewede R; Hausinger F
    Thorac Cardiovasc Surg; 1989 Oct; 37(5):281-4. PubMed ID: 2588245
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Postresection irradiation for primary lung cancer.
    Green N; Kurohara SS; George FW; Crews QE
    Radiology; 1975 Aug; 116(02):405-7. PubMed ID: 1153744
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinicopathological factors associated with unexpected N3 in patients with mediastinal lymph node involvement.
    Sakao Y; Miyamoto H; Oh S; Takahashi N; Sakuraba M
    J Thorac Oncol; 2007 Dec; 2(12):1107-11. PubMed ID: 18090583
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The long-term survival of patients with lung cancer treated surgically after selection by mediastinoscopy.
    Nohl-Oser HC
    Thorac Cardiovasc Surg; 1980 Jun; 28(3):158-61. PubMed ID: 6156508
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term survival in bronchogenic carcinoma.
    Ashor GL; Kern WH; Meyer BW; Lindesmith GG; Stiles QR; Tucker BL; Jones JC
    J Thorac Cardiovasc Surg; 1975 Oct; 70(4):581-9. PubMed ID: 170481
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Border between N1 and N2 stations in lung carcinoma: lessons from lymph node metastatic patterns of lower lobe tumors.
    Okada M; Sakamoto T; Yuki T; Mimura T; Nitanda H; Miyoshi K; Tsubota N
    J Thorac Cardiovasc Surg; 2005 Apr; 129(4):825-30. PubMed ID: 15821650
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adjuvant treatment using transfer factor for bronchogenic carcinoma: long-term follow-up.
    Whyte RI; Schork MA; Sloan H; Orringer MB; Kirsh MM
    Ann Thorac Surg; 1992 Mar; 53(3):391-6. PubMed ID: 1540053
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.